Skip to main content
Premium Trial:

Request an Annual Quote

Tempus: Ned Sharpless

Tempus said that Norman "Ned" Sharpless will serve as a senior strategic advisor to the company. Sharpless was most recently director of the National Cancer Institute, part of the National Institutes of Health, a position he held from 2017 to 2022. He also served as acting commissioner for the US Food and Drug Administration in 2019 before return to NCI. Prior to his time at NCI, Sharpless was director of the University of North Carolina Lineberger Comprehensive Cancer Center. He received his MD from the UNC School of Medicine, and completed his clinical training at Massachusetts General Hospital and the Dana-Farber Cancer Institute, both of Harvard Medical School.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.